Amarin Plc Stock Today
| AMRN Stock | USD 13.72 0.24 1.72% |
PerformanceWeakest
| Odds Of DistressLow
|
Amarin PLC is selling at 13.72 as of the 4th of January 2026; that is 1.72 percent decrease since the beginning of the trading day. The stock's open price was 13.96. Amarin PLC has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 6th of October 2025 and ending today, the 4th of January 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of April 1993 | Category Healthcare | Classification Health Care |
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. The company has 20.79 M outstanding shares of which 406.78 K shares are presently shorted by private and institutional investors with about 4.77 trading days to cover. More on Amarin PLC
Moving against Amarin Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Amarin Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Patrick Holt | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAmarin PLC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amarin PLC's financial leverage. It provides some insight into what part of Amarin PLC's total assets is financed by creditors.
| |||||
Amarin PLC (AMRN) is traded on NASDAQ Exchange in USA and employs 275 people. Amarin PLC is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 285.28 M. Amarin PLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 20.79 M outstanding shares of which 406.78 K shares are presently shorted by private and institutional investors with about 4.77 trading days to cover.
Amarin PLC currently holds about 303.7 M in cash with (31.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check Amarin PLC Probability Of Bankruptcy
Ownership AllocationAmarin PLC holds a total of 20.79 Million outstanding shares. Almost 77.77 percent of Amarin PLC outstanding shares are held by general public with 1.9 (percent) owned by insiders and only 20.33 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amarin Ownership Details
Amarin Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2025-06-30 | 45.2 K | |
| Lcm Capital Management, Inc | 2025-06-30 | 42.9 K | |
| Susquehanna International Group, Llp | 2025-06-30 | 42.8 K | |
| Jump Financial Llc | 2025-06-30 | 38.4 K | |
| George Kaiser Family Foundation | 2025-06-30 | 38.2 K | |
| Trexquant Investment Lp | 2025-06-30 | 32.7 K | |
| Sei Investments Co | 2025-06-30 | 27.9 K | |
| Resources Investment Advisors Inc | 2025-06-30 | 27.6 K | |
| Bleakley Financial Group Llc | 2025-06-30 | 23.5 K | |
| Sarissa Capital Management Lp | 2025-06-30 | 1.2 M | |
| Kynam Capital Management, Lp | 2025-06-30 | 576.1 K |
Amarin PLC Historical Income Statement
Amarin Stock Against Markets
Amarin PLC Corporate Management
| Jason JD | Chief VP | Profile | |
| Joseph JD | Exec Counsel | Profile | |
| Jordan Zwick | Senior Relations | Profile | |
| Alina Kolomeyer | Director Communications | Profile | |
| Nabil Abadir | Chief Affairs | Profile |
Already Invested in Amarin PLC?
The danger of trading Amarin PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amarin PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amarin PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amarin PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amarin PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amarin PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amarin Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amarin Plc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share (4.20) | Revenue Per Share | Quarterly Revenue Growth 0.174 | Return On Assets |
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.